Bone Metastases - Featured Article

Article

Bone Complications: An Unavoidable Side-Effect of Cancer Treatment in the Elderly?

 

Osteoprosis and osteopenia and are increasingly common in cancer patients, due both to the aging population and new forms of cancer treatment. This week we feature

Lodovico Balducci's article

on bone complications of cancer treatment in the elderly. One of ONCOLOGY's own Editors in Chief, Bill Wood from the UNC Lineberger Comprehensive Cancer Center

comments

, and Drs Cohen and Naeim from the David Geffen School of Medicine also share their

viewpoint 

on this topic of increasing importance.

Newsletter

Stay up to date on recent advances in the multidisciplinary approach to cancer.

Recent Videos
5 experts are featured in this series
2 experts are featured in this series.
5 experts are featured in this series
2 experts are featured in this series.
Taletrectinib showed improved efficacy in patients with ROS1-positive non–small cell lung cancer who were treatment-naïve.
“It’s a drug that I’m very comfortable with, and it is a drug I’ll likely use primarily in the first-line setting,” stated Jorge Nieva, MD, on taletrectinib in non–small cell lung cancer.
4 experts in this video
4 experts in this video
Those being treated for peritoneal carcinomatosis may not have to experience the complication rates or prolonged recovery associated with surgical options.
For patients with peritoneal carcinomatosis, integrating PIPAC into a treatment regimen does not interrupt their systemic therapy.